𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lignin and ethylcellulose as polymers in controlled release formulations of urea

✍ Scribed by M. Fernández-Pérez; F. J. Garrido-Herrera; E. González-Pradas; M. Villafranca-Sánchez; F. Flores-Céspedes

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
349 KB
Volume
108
Category
Article
ISSN
0021-8995

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of bentonite and humic acid as modif
Use of bentonite and humic acid as modifying agents in alginate-based controlled-release formulations of imidacloprid
✍ González-Pradas, E; Fernández-Pérez, M; Villafranca-Sánchez, M; Martínez-López, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

In order to prepare a formulation to be used for controlled release, imidacloprid was incorporated into alginate granules by using calcium chloride as gellant. The formulation prepared (alginate±imidacloprid±water) was modi®ed by the addition of different sorbents. The effects on release rate of the

In vitro and in vivo evaluation of contr
In vitro and in vivo evaluation of controlled-release and enteric-coated formulations of sodium salicylate
✍ Lars Borgström; Bo Ekman; Hans Larsson; Ido Leden; Åke Lindahl; Arne Melander; E 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English

The bioavailability and pharmacokinetics of salicylic acid (SA) were studied after single and multiple doses of a new slow-release formulation, based on porous membrane diffusion of sodium salicylate (NaSA). A solution of NaSA and an enteric-coated tablet of NaSA were used for comparison. Dissolutio

Mobility of imidacloprid from alginate-b
Mobility of imidacloprid from alginate-bentonite controlled-release formulations in greenhouse soils
✍ González-Pradas, E; Fernández-Pérez, M; Villafranca-Sánchez, M; Flores-Céspedes, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

The mobility of imidacloprid [1-(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine] from alginate-based controlled-release (CR) formulations was investigated in two different soil pro®les. In one, a layered bed system simulating the typical arrangement under a plastic greenhouse, which is com

Comparative clinical efficacy and safety
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain
✍ Neil A. Hagen; Najib Babul 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

Fredphone, each given every 12 hours for 7 days. Pain intensity, nausea, and sedation erick, Pickering, Ontario, Canada. were assessed by patients four times daily, and breakthrough analgesia was recorded. ## RESULTS. Thirty-one patients completed the study (18 women, 13 men; mean age, 56 { 3 ye

Bioavailability of pseudoephedrine from
Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers
✍ Vaishali Pade; Jagadeesh Aluri; Linda Manning; Salomon Stavchansky 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

A multiple-dose bioequivalence study with six healthy human volunteers was conducted. The bioavailability of an experimental controlled release tablet containing pseudoephedrine was compared with a marketed controlled release pseudoephedrine capsule in a three-way crossover study. Plasma samples, co